Study protocol: High-protein nutritional intervention based on β-hydroxy-β-methylbutirate, vitamin D3 and calcium on obese and lean aged patients with hip fractures and sarcopenia. the HIPERPROT-GER study

Maturitas

Volumn 76, Issue 2, 2013, Pages 123-128

  Malafarina, Vincenzo ^a   Uriz Otano, Francisco ^a   Gil Guerrero, Lucía ^a   Iniesta, Raquel ^b   Zulet, Angeles ^c,d   Alfredo Martinez, J ^a  

^a Hospital San Juan di Dios   (Spain)

^b Servicio de Soportes Estadístico   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

High protein; Hip fracture; Obesity; Older people; Sarcopenia; Hydroxy methylbutirate

Indexed keywords

BETA HYDROXY BETA METHYLBUTYRATE; BUTYRIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; UNCLASSIFIED DRUG;

AGED; AGING; ARTICLE; BARTHEL INDEX; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERIATRIC REHABILITATION; HIP FRACTURE; HOSPITALIZATION; HUMAN; MALE; NUTRITIONAL ASSESSMENT; OBESITY; PROSPECTIVE STUDY; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; SARCOPENIA;

HIGH PROTEIN; HIP FRACTURE; OBESITY; OLDER PEOPLE; SARCOPENIA; Β-HYDROXY-Β-METHYLBUTIRATE;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; CALCIUM; CHOLECALCIFEROL; DIETARY PROTEINS; FEMALE; HIP FRACTURES; HUMANS; MALE; MUSCLE STRENGTH; OBESITY; PROSPECTIVE STUDIES; SARCOPENIA; STATISTICS, NONPARAMETRIC; VALERATES; WALKING;

EID: 84888641312     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.06.016     Document Type: Article

References (47)

1. Cruz-Jentoft AJ, Triana FC, Gomez-Cabrera MC, et al. The emergent role of sarcopenia: Preliminary report of the Observatory of Sarcopenia of the Spanish Society of Geriatrics and Gerontology. Revista Espanola de Geriatria y Gerontologia 2011;46(2):100-10.
2. Masanes F, Culla A, Navarro-Gonzalez M, et al. Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). The Journal of Nutrition, Health & Aging 2012;16(2):184-7.
3. Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 2002;26(7):953-60.
4. Malafarina V, Uriz Otano F, Iniesta R, Gil-Guerrero L. Sarcopenia in the elderly: Diagnosis, physiopathology and treatment. Maturitas 2012;71(2):109-14.
5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing 2010;39(4):412-23.
6. Parr EB, Coffey VG, Hawley JA. ?Sarcobesity?: A metabolic conundrum. Maturitas 2013;74(2):109-13.
7. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: Definition, cause and consequences. Current Opinion in Clinical Nutrition and Metabolic Care 2008;11(6):693-700.
8. Sorkin JD, Muller DC, Andres R. Longitudinal change in the heights of men and women: Consequential effects on body mass index. Epidemiologic Reviews 1999;21(2):247-60.
9. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: A new category of obesity in the elderly. Nutrition, Metabolism, and Cardiovascular Diseases 2008;18(5):388-95.
10. Bouchard DR, Dionne IJ, Brochu M. Sarcopenic/obesity and physical capacity in older men and women: Data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study. Obesity (Silver Spring Md) 2009;17(11):2082-8.
11. Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: A focus on sarcopenic obesity. Archives of Gerontology and Geriatrics 2013;56(1):270-8.
12. Davison KK, Ford ES, Cogswell ME, Dietz WH. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. Journal of the American Geriatrics Society 2002;50(11):1802-9.
13. Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in communitydwelling elderly women: The EPIDOS (EPIDemiologie de l?OSteoporose) Study. The American Journal of Clinical Nutrition 2009;89(6):1895-900.
14. Childers DK, Allison DB. The ?obesity paradox?: A parsimonious explanation for relations among obesity, mortality rate and aging? International Journal of Obesity (2005) 2010;34(8):1231-8.
15. Dorner TE, Rieder A. Obesity paradox in elderly patients with cardiovascular diseases. International Journal of Cardiology 2012;155(1):56-65.
16. Bardales Mas Y, Gonzalez Montalvo JI, Abizanda Soler P, Alarcon Alarcon MT. Hip fracture guidelines. a comparison of the main recommendations. Revista Espanola de Geriatria y Gerontologia 2012;47(5):220-7.
17. Paillaud E, Bories PN, Le Parco JC, Campillo B. Nutritional status and energy expenditure in elderly patients with recent hip fracture during a 2-month follow-up. British Journal of Nutrition 2000;83(2):97-103.
18. Wyers CE, Breedveld-Peters JJL, Reijven PLM, et al. Efficacy and costeffectiveness of nutritional intervention in elderly after hip fracture: Design of a randomized controlled trial. BMC Public Health 2010;10:212.
19. Volkert D, Berner YN, Berry E, et al. ESPEN guidelines on enteral nutrition: geriatrics. Clinical Nutrition 2006;25(2):330-60.
20. Vukovich MD, Stubbs NB, Bohlken RM. Body composition in 70-year-old adults responds to dietary beta-hydroxy-beta-methylbutyrate similarly to that of young adults. Journal of Nutrition 2001;131(7):2049-52.
21. Flakoll P, Sharp R, Baier S, Levenhagen D, Carr C, Nissen S. Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition 2004;20(5):445-51.
22. Baier S, Johannsen D, Abumrad N, Rathmacher JA, Nissen S, Flakoll P. Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), l-arginine, and l-lysine. Journal of Parenteral and Enteral Nutrition 2009;33(1):71-82.
23. Gonzalez Pardo V, Russo de Boland A. Age-related changes in the response of intestinal cells to 1 alpha, 25(OH)(2)-vitamin D-3. Ageing Research Reviews 2013;12(1):76-89.
24. Rizzoli R, Boonen S, Brandi M, et al. Vitamin D supplementation in elderly or postmenopausal women: A 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Current Medical Research and Opinion 2013;29(4):305-13.
25. Bird M, Hill KD, Robertson IK, Ball MJ, Pittaway J, Williams AD. Serum [25(OH)D] status, ankle strength and activity show seasonal variation in older adults: Relevance for winter falls in higher latitudes. Age and Ageing 2013; 42(2) 181-5.
26. Houston DK, Neiberg RH, Tooze JA, et al. Low 25-hydroxyvitamin D predicts the onset of mobility limitation and disability in community-dwelling older adults: The Health ABC Study. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences 2013;68(2):181-7.
27. Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. Journal of the American Medical Directors Association 2010;11(6):391-6.
28. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Maryland State Medical Journal 1965;14:61-5.
29. Abizanda P, Lopez-Jimenez M, Lopez-Torres J, Atienzar-Nunez P, Naranjo JM, McAuley E. Validation of the spanish version of the short-form late-life function and disability instrument. Journal of the American Geriatrics Society 2011;59(5):893-9.
30. Denkinger MD, Igl W, Coll-Planas L, Bleicher J, Nikolaus T, Jamour M. Evaluation of the short form of the late-life function and disability instrument in geriatric inpatients-validity, responsiveness, and sensitivity to change. Journal of the American Geriatrics Society 2009;57(2):309-14.
31. Viosca E, Martinez JL, Almagro PL, Gracia A, Gonzalez C. Proposal and validation of a new functional ambulation classification scale for clinical use. Archives of Physical Medicine and Rehabilitation 2005;86(6):1234-8.
32. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189-98.
33. Malafarina V, Uriz-Otano F, Gil-Guerrero L. Nutritional assessment and treatment of sarcopenia. Revista Espanola de Geriatria y Gerontologia 2013 [in press].
34. Cuervo M, Garcia A, Ansorena D, et al. Nutritional assessment interpretation on 22 007 Spanish community-dwelling elders through the Mini Nutritional Assessment test. Public Health Nutrition 2009;12(1):82-90.
35. Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutrition Reviews 1996;54(1 Pt 2):S59-65.
36. Cuervo M, Ansorena D, Martinez-Gonzalez MA, Garcia A, Astiasaran I, Martinez JA. Impact of global and subjective mini nutritional assessment (MNA) questions on the evaluation of the nutritional status: The role of gender and age. Archives of Gerontology and Geriatrics 2009;49(1):69-73.
37. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. Journal of Clinical Epidemiology 1994;47(11):1245-51.
38. Abizanda Soler P, Paterna Mellinas G, Martinez Sanchez E, Lopez Jimenez E. Comorbidity in the elderly: utility and validity of assessment tools. Revista Espanola de Geriatria y Gerontologia 2010;45(4):219-28.
39. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. American Journal of Epidemiology 2004;159(4):413-21.
40. Janssen I. Influence of sarcopenia on the development of physical disability: The Cardiovascular Health Study. Journal of the American Geriatrics Society 2006;54(1):56-62.
41. Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: Towards a standardised approach. Age and Ageing 2011;40(4):423-9.
42. Bautmans I, Onyema O, Van Puyvelde K, Pleck S, Mets T. Grip work estimation during sustained maximal contraction: validity and relationship with dependency and inflammation in elderly persons. The Journal of Nutrition, Health & Aging 2011;15(8):731-6.
43. Dufour AB, Hannan MT, Murabito JM, Kiel DP, McLean RR. Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: The framingham study. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences 2013;68(2):168-74.
44. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obesity Research 2004;12(12):1995-2004.
45. Latham NK, Anderson CS, Reid IR. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: A systematic review. Journal of the American Geriatrics Society 2003;51(9):1219-26.
46. Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Appendicular lean mass does not mediate the significant association between vitamin D status and functional outcome in hip-fracture women. Archives of Physical Medicine and Rehabilitation 2011;92(2):271-6.
47. Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: A systematic review. Journal of the American Medical Directors Association 2013;14(1):10-7.